Nvidia and Eli Lilly Commit $1 Billion to AI Drug Discovery Lab
The five-year joint venture pairs Nvidia's compute infrastructure with Lilly's pharmaceutical expertise, betting that AI can meaningfully accelerate drug discovery timelines.
Subscribe to unlock all stories
Get full access to The Singularity Ledger, archive included.
Cancel anytime. Payments powered by Stripe.